ABOUT THIS STUDY
- Healthy male and/or female subjects between the ages of 18 and 55 years, inclusive.
- Subjects who display the CYP2D6 extensive, intermediate, ultra-rapid, or poor metabolizer statuses.
- A known history of hypersensitivity or previous intolerance to Dimebon or other
- Subjects with any previous history of seizures, convulsions, epilepsy, or significant
- Evidence or history of clinically significant hematological, renal, endocrine,
pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or
allergic disease (including drug allergies, but excluding untreated, asymptomatic,
seasonal allergies at time of dosing).
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Overland Park, Kansas
- Philadelphia, Pennsylvania
- Yokohama, Kanagawa
- Minato-ku, Tokyo
- Shinjuku-ku, Tokyo